Boundless Bio Inc.'s market cap is currently $28.43M. The company's EPS TTM is $-0.7; its P/E ratio is ―; Boundless Bio Inc. is scheduled to report earnings on August 5, 2025, and the estimated EPS forecast is $-0.58. See an overview of income statement, balance sheet, and cash flow financials.
